Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats.
about
Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic EventsAdvances in the epidemiology of heart failure and left ventricular remodelingNeutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeuticsSinapic acid prevents hypertension and cardiovascular remodeling in pharmacological model of nitric oxide inhibited ratsAdeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling.Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase IInnovative Therapeutics: Designer Natriuretic Peptides.Cardiac BNP gene delivery prolongs survival in aged spontaneously hypertensive rats with overt hypertensive heart disease.Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP.Targeted gene-silencing reveals the functional significance of myocardin signaling in the failing heartSalvianolic acid A, a novel matrix metalloproteinase-9 inhibitor, prevents cardiac remodeling in spontaneously hypertensive rats.Beta cell regeneration after single-round immunological destruction in a mouse model.B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension.An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated VirusesTransgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females.Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy.Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease.Natriuretic Peptide Receptor B modulates the proliferation of the cardiac cells expressing the Stem Cell Antigen-1.Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.Natriuretic peptides in cardiometabolic regulation and disease.Angiotensin receptor neprilysin inhibitor LCZ696: pharmacology, pharmacokinetics and clinical development.B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease.Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.Sustained blood pressure-lowering actions of subcutaneous B-type natriuretic peptide (nesiritide) in a patient with uncontrolled hypertension.Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.Brain natriuretic peptide is able to stimulate cardiac progenitor cell proliferation and differentiation in murine hearts after birth.Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7).Impaired β-cell glucokinase as an underlying mechanism in diet-induced diabetes.
P2860
Q26765883-045B66CD-6B21-416D-B320-102191662DB1Q26778333-C3C343AF-31C0-42D2-A308-32E0CFEB784AQ26827147-38529239-9712-4BD7-A66A-80D1DF5A5D6BQ27004000-A2809225-5AED-4A4C-A422-53DA52AB75CCQ28542819-1FD2E840-CB61-4FBB-9219-5FDAC62BC468Q30417445-2898E44F-81AD-4B8A-97A0-E1602B6D0D4CQ30539041-E5BD5D62-AF89-4D68-AE14-68CA7C63B832Q33653332-76B68AAC-1451-4876-BB76-7376C40AC0E3Q33657331-79C5E35A-0420-4946-8F62-BD7EE7DDB914Q33698918-DC3D7E06-952C-438B-AB4C-2E29C8A14E58Q34058563-16E9FB2D-1F54-4C44-B338-FA5B17DD3AE7Q34637895-8213B8B6-7270-440E-915E-D489C50CFA63Q34877390-AE3D1018-4A11-4005-9DD3-5B00EEED03C2Q35742577-A593A11E-C372-4541-B452-98F5DF4D710AQ35920744-B5BACE06-C140-46AC-9735-C6A6FE869285Q36839889-9F7CAC40-9653-4E81-99DC-C73F549C366FQ36886130-5F5CBE64-19BD-40F6-A6D6-8E9269A5437AQ37137787-EDAC5F5B-23DD-423C-A0E7-44F5BF3594D6Q37172401-F21D2562-DFBD-44E8-A186-8E015DC7585FQ37633335-85AD1CD7-C0FF-4C4C-8D31-01930B8CBFECQ37914058-1356A586-42AA-48F7-9191-74A5970D1823Q38211333-2D6B002F-79A9-4160-9ED9-792F0EBA7B4DQ38790076-C82590B0-7AA6-4F74-AC35-7C4C8DD58AE6Q38833791-CE27A7B2-6DC2-4C0F-826C-49EB6B89A563Q41025346-3090AF1F-DFC7-41D1-989B-39CCBF1C8E79Q42336975-3E5CFA73-E0A0-4370-9311-8E99655C6BD1Q47855200-1E711932-94C5-48F6-800F-9B6C08F924DAQ48435084-A3027D3C-4DAC-4CB8-9B11-328F477FBADDQ54326718-0D80BC08-6509-4F96-8E41-46625BF89106Q55519019-C9E50CE0-B040-4CD4-B1D1-27D234958286
P2860
Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Long-term cardiac pro-B-type n ...... ontaneously hypertensive rats.
@en
type
label
Long-term cardiac pro-B-type n ...... ontaneously hypertensive rats.
@en
prefLabel
Long-term cardiac pro-B-type n ...... ontaneously hypertensive rats.
@en
P2093
P2860
P1433
P1476
Long-term cardiac pro-B-type n ...... ontaneously hypertensive rats.
@en
P2093
Alessandro Cataliotti
Diego Bellavia
Elise A Oehler
Fernando L Martin
Gerald E Harders
Jarryd M Campbell
Jason M Tonne
John C Burnett
Kaw-Whye Peng
Lorenzo S Malatino
P2860
P304
P356
10.1161/CIRCULATIONAHA.110.981720
P407
P577
2011-03-14T00:00:00Z